tag:blogger.com,1999:blog-6211405954943098401.post4272666711703704340..comments2023-11-20T00:23:16.290+01:00Comments on Stethoscope On Rome: Battling the Coronavirus: Treatment and VaccinesSusan Levenstein, MDhttp://www.blogger.com/profile/04664082134917253721noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-6211405954943098401.post-43517495874554663882021-09-06T11:57:26.331+02:002021-09-06T11:57:26.331+02:00Good question. The EMA authorized REGEN-COV for em...Good question. The EMA authorized REGEN-COV for emergency use back in February, for high-risk COVID-19 outpatients, but it's being vastly underused, partly because of the logistics of intravenous infusion but also, I think, because of ignorance (as in the US too). The use for prevention in household contacts was only approved in the US a month ago and the EU always lags behind. But I doubt wholesale prevention will ever catch on, because the drug costs more than $1000 - its use should in my opinion be limited to contacts at high risk for severe disease.Susan Levenstein, MDhttps://www.blogger.com/profile/04664082134917253721noreply@blogger.comtag:blogger.com,1999:blog-6211405954943098401.post-82925341330590062342021-09-06T07:06:21.628+02:002021-09-06T07:06:21.628+02:00Hi Susan, thank you very much for this update. A q...Hi Susan, thank you very much for this update. A quick question: why do you think REGEN-COV has not caught on, and the European Medicines Agency is silent? Reason I ask, REGEN-COV would be useful for my home country instead of relying on Ivermectin :(. Will share your post with PH friends.<br /><br />Mapzhttps://www.blogger.com/profile/12392671920714087646noreply@blogger.com